Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia
Background Chronic lymphocytic leukemia (CLL) primarily affects older persons who often
have coexisting conditions in addition to disease-related immunosuppression and …
have coexisting conditions in addition to disease-related immunosuppression and …
[PDF][PDF] Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia
NL Bartlett - 2015 - digitalcommons.wustl.edu
BACKGROUND Chronic lymphocytic leukemia (CLL) primarily affects older persons who
often have coexisting conditions in addition to disease-related immunosuppression and …
often have coexisting conditions in addition to disease-related immunosuppression and …
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
JA Burger, A Tedeschi, PM Barr… - The New England …, 2015 - pubmed.ncbi.nlm.nih.gov
Background Chronic lymphocytic leukemia (CLL) primarily affects older persons who often
have coexisting conditions in addition to disease-related immunosuppression and …
have coexisting conditions in addition to disease-related immunosuppression and …
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
JA Burger, A Tedeschi, PM Barr, T Robak… - New England Journal …, 2015 - escholarship.org
BackgroundChronic lymphocytic leukemia (CLL) primarily affects older persons who often
have coexisting conditions in addition to disease-related immunosuppression and …
have coexisting conditions in addition to disease-related immunosuppression and …
[引用][C] Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
J Burger, A Tedeschi, P Barr, T Robak… - NEW ENGLAND …, 2015 - avesis.deu.edu.tr
[HTML][HTML] Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
JA Burger, A Tedeschi, PM Barr, T Robak… - The New England …, 2015 - ncbi.nlm.nih.gov
BACKGROUND Chronic lymphocytic leukemia (CLL) primarily affects older persons who
often have coexisting conditions in addition to disease-related immunosuppression and …
often have coexisting conditions in addition to disease-related immunosuppression and …
[HTML][HTML] Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia
J Burger, A Tedeschi, P Barr, T Robak… - NEW ENGLAND …, 2015 - iris.uniroma1.it
BACKGROUND: Chronic lymphocytic leukemia (CLL) primarily affects older persons who
often have coexisting conditions in addition to disease-related immunosuppression and …
often have coexisting conditions in addition to disease-related immunosuppression and …
Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia
JA Burger, A Tedeschi, PM Barr, T Robak… - New England Journal …, 2015 - diposit.ub.edu
Background: chronic lymphocytic leukemia (CLL) primarily affects older persons who often
have coexisting conditions in addition to disease-related immunosuppression and …
have coexisting conditions in addition to disease-related immunosuppression and …
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia.
JA Burger, A Tedeschi, PM Barr, T Robak… - New England Journal …, 2015 - dial.uclouvain.be
(eng) BACKGROUND: Chronic lymphocytic leukemia (CLL) primarily affects older persons
who often have coexisting conditions in addition to disease-related immunosuppression and …
who often have coexisting conditions in addition to disease-related immunosuppression and …
Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia
JA Burger, A Tedeschi, PM Barr, T Robak… - … England Journal of …, 2015 - research.uniupo.it
Background Chronic lymphocytic leukemia (CLL) primarily affects older persons who often
have coexisting conditions in addition to disease-related immunosuppression and …
have coexisting conditions in addition to disease-related immunosuppression and …